First International Bank & Trust Has $619,000 Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

First International Bank & Trust lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 3.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,310 shares of the healthcare conglomerate’s stock after purchasing an additional 47 shares during the period. First International Bank & Trust’s holdings in UnitedHealth Group were worth $619,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of UNH. MFA Wealth Advisors LLC raised its holdings in UnitedHealth Group by 4.8% in the 3rd quarter. MFA Wealth Advisors LLC now owns 414 shares of the healthcare conglomerate’s stock worth $209,000 after acquiring an additional 19 shares during the period. Formidable Asset Management LLC increased its holdings in shares of UnitedHealth Group by 1.5% during the 3rd quarter. Formidable Asset Management LLC now owns 1,366 shares of the healthcare conglomerate’s stock worth $741,000 after purchasing an additional 20 shares during the period. Apeiron RIA LLC increased its holdings in shares of UnitedHealth Group by 0.8% during the 1st quarter. Apeiron RIA LLC now owns 2,581 shares of the healthcare conglomerate’s stock worth $1,222,000 after purchasing an additional 20 shares during the period. McElhenny Sheffield Capital Management LLC increased its holdings in shares of UnitedHealth Group by 1.6% during the 4th quarter. McElhenny Sheffield Capital Management LLC now owns 1,317 shares of the healthcare conglomerate’s stock worth $698,000 after purchasing an additional 21 shares during the period. Finally, First Bank & Trust increased its holdings in shares of UnitedHealth Group by 1.9% during the 4th quarter. First Bank & Trust now owns 1,115 shares of the healthcare conglomerate’s stock worth $591,000 after purchasing an additional 21 shares during the period. Institutional investors and hedge funds own 92.61% of the company’s stock.

Insider Activity at UnitedHealth Group

In related news, CEO Andrew Witty sold 6,160 shares of the stock in a transaction that occurred on Thursday, April 27th. The shares were sold at an average price of $487.49, for a total value of $3,002,938.40. Following the transaction, the chief executive officer now directly owns 86,564 shares in the company, valued at $42,199,084.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other UnitedHealth Group news, CEO Andrew Witty sold 6,160 shares of the stock in a transaction on Thursday, April 27th. The shares were sold at an average price of $487.49, for a total value of $3,002,938.40. Following the sale, the chief executive officer now directly owns 86,564 shares in the company, valued at $42,199,084.36. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,008 shares of the stock in a transaction on Friday, April 21st. The stock was sold at an average price of $484.58, for a total transaction of $488,456.64. Following the completion of the sale, the executive vice president now owns 10,359 shares in the company, valued at $5,019,764.22. The disclosure for this sale can be found here. Insiders have sold 8,852 shares of company stock worth $4,313,962 over the last ninety days. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $482.69 on Wednesday. UnitedHealth Group Incorporated has a 1 year low of $445.68 and a 1 year high of $558.10. The firm’s 50 day moving average is $484.23 and its 200-day moving average is $491.07. The firm has a market capitalization of $449.40 billion, a price-to-earnings ratio of 22.07, a PEG ratio of 1.40 and a beta of 0.68. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its earnings results on Friday, April 14th. The healthcare conglomerate reported $6.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.24 by $0.02. UnitedHealth Group had a net margin of 6.16% and a return on equity of 27.05%. The company had revenue of $91.93 billion for the quarter, compared to analyst estimates of $89.77 billion. During the same period in the prior year, the business earned $5.49 earnings per share. UnitedHealth Group’s quarterly revenue was up 14.7% on a year-over-year basis. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 24.86 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 27th. Investors of record on Monday, June 19th were issued a $1.88 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.65. This represents a $7.52 annualized dividend and a yield of 1.56%. The ex-dividend date of this dividend was Thursday, June 15th. UnitedHealth Group’s dividend payout ratio is currently 34.39%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Royal Bank of Canada restated an “outperform” rating and set a $592.00 price objective on shares of UnitedHealth Group in a report on Monday, April 17th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of UnitedHealth Group from $627.00 to $564.00 in a research note on Friday, June 16th. Stephens reissued an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research note on Tuesday, February 28th. Raymond James reissued a “strong-buy” rating and issued a $630.00 target price on shares of UnitedHealth Group in a research note on Friday, April 14th. Finally, Piper Sandler assumed coverage on shares of UnitedHealth Group in a research note on Thursday, May 25th. They issued an “overweight” rating and a $580.00 target price on the stock. One analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $592.68.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.